RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Paul Edward Kelly bought $65K of Relmada Therapeutics, Inc.
Bought$64,750
$2.59Price
25,000Shares
+13%Stake
What RLMD did for a copier
- $1,000 copied at Wed, Sep 11 close, $3.02
- $1,190
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Oct 23 close.
Paul Edward Kelly's record
5 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Sep 9. Filed Wed, Sep 11, 1:46 PM ET, during the session. Returns use the Sep 11 close and the Oct 23 close. Not investment advice.